SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing intense post-earnings volatility as an unexpected CEO transition announcement overshadowed strong revenue and earnings results, fueling concerns about the firm's strategic direction in the AI era. While the community remains deeply divided between bargain hunters focusing on consistent fundamental growth and skeptics fearing that generative AI tools will erode the company's long-term competitive moat.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is trending as market participants react to intensifying Middle East geopolitical tensions and surging oil prices, which are fueling concerns over inflation and potential economic headwinds. The community is sharply divided, with many traders debating the validity of 'buy-the-dip' strategies amid increased volatility and skepticism toward government-led market stabilization efforts.

Trump For President

The TRUMP crypto token is currently trending as investors debate whether it acts as a genuine political expression or a high-risk pump-and-dump scheme. Community discussions are sharply divided, with supporters highlighting speculative potential and opposition pointing to its declining price action and intense political scrutiny.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is currently trending as investors weigh recent reports of in-house AI chip development against broader market skepticism regarding the sustainability of heavy AI-related capital expenditures. The community remains divided, with some traders viewing recent price volatility as a long-term buying opportunity in a fundamental powerhouse, while others express frustration over the stock's tendency to struggle with resistance levels and its sensitivity to negative geopolitical headlines.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is trending as investors react to a significant analyst price target increase following the company's recent disclosure of positive clinical data for its obesity candidate, WVE-007. The community is actively discussing the drug's potential as a 'muscle-sparing' alternative to GLP-1 therapies, alongside heavy speculation regarding a potential M&A buyout as Big Pharma scrambles to replenish pipelines with innovative weight-loss assets.

Kyivstar Group Ltd. engages in the telecommunications and digital business. It provides mobile, digital and fixed-line services. The company was founded in 1994 and is headquartered in Dubai, United Arab Emirates.

Kyivstar Group Ltd.

Kyivstar Group is attracting significant community attention as investors view it as a primary pure-play proxy for Ukraine's economic recovery and potential peace negotiations. Discussions are heavily focused on the company's resilient fundamentals, recent Starlink direct-to-cell integration, and the speculative upside tied to geopolitical developments.

ProShares Trust - ProShares UltraShort Bloomberg Crude Oil -2x Shares

ProShares UltraShort Bloomberg Crude Oil

The community is actively debating the heavy decay and potential delisting risks of the inverse oil ETF SCO as it faces high volatility amid geopolitical tensions. Traders are heavily split between those attempting to time a short-term reversal in crude oil and others cautioning against holding these leveraged instruments due to their structural performance erosion.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics is currently the center of investor discussion following the official rollout of its Eversense 365 integrated with the Twiist automated insulin delivery system, a milestone many view as a pivotal step in expanding its competitive footprint. While supporters highlight this product integration as a long-term growth catalyst, the community remains deeply divided, with many retail investors expressing frustration over the stock's recent price volatility and ongoing concerns regarding the company's long-term leadership and commercial execution.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is experiencing significant volatility driven by escalating geopolitical tensions in the Middle East and spiking oil prices, which have triggered broader market concerns about inflation and systemic financial stability. While some market participants are betting on a relief rally and Fed rate intervention, the community remains deeply divided, with active discussions focusing on algorithmic manipulation, high-risk oil supply chain disruptions, and the long-term impact of rising energy costs on tech-heavy valuations.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is trending following the announcement of a development agreement with Tower Semiconductor to integrate its electro-optic polymer modulators into the PH18 silicon photonics platform. Community discussions are split between strong bullish sentiment, driven by the potential for high-bandwidth AI infrastructure adoption, and intense skepticism regarding the company's long-term path to commercial revenue and history of dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Halozyme Appoints David Ramsay As Interim CFO

(RTTNews) - Halozyme Therapeutics Inc. (HALO), on Thursday, appointed David Ramsay as interim chief financial officer, effective March 23...

Halozyme Appoints David Ramsay as Interim Chief Financial Officer

Halozyme Appoints David Ramsay as Interim Chief Financial Officer Halozyme Appoints David Ramsay as Interim Chief Financial Officer PR Newswire SAN DIEGO, March 12, 2026 SAN DIEGO, March 12, 2026...

Capital Fund Management S.A. Has $15.60 Million Stake in Halozyme Therapeutics, Inc. $HALO

Capital Fund Management S.A. grew its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 97.1% during the third quarter, according to the company in its most recent disclosure...

Insider Selling: Cortney Caudill Unloads $1.96M Of Halozyme Therapeutics Stock

Insider Selling: Halozyme Therapeutics (NASDAQ:HALO) COO Sells 8,857 Shares of Stock

Halozyme Therapeutics, Inc. (NASDAQ:HALO - Get Free Report) COO Cortney Caudill sold 8,857 shares of Halozyme Therapeutics stock in a transaction that occurred on Tuesday, March 10th. The stock was...

Halozyme Therapeutics, Inc. $HALO Shares Purchased by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP lifted its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 3.2% during the 3rd quarter, according to its most recent filing with the Securities and...

Halozyme Therapeutics (NASDAQ:HALO) COO Cortney Caudill Sells 8,857 Shares

Halozyme Therapeutics, Inc. (NASDAQ:HALO - Get Free Report) COO Cortney Caudill sold 8,857 shares of the company's stock in a transaction on Tuesday, March 10th. The stock was sold at an average...

Insider Selling: Halozyme Therapeutics (NASDAQ:HALO) COO Sells 20,000 Shares of Stock

Halozyme Therapeutics, Inc. (NASDAQ:HALO - Get Free Report) COO Cortney Caudill sold 20,000 shares of the firm's stock in a transaction dated Monday, March 9th. The stock was sold at an average price...

DLD Asset Management LP Has $2.20 Billion Position in Halozyme Therapeutics, Inc. $HALO

DLD Asset Management LP raised its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 20.0% during the third quarter, according to the company in its most recent 13F filing with...

Victory Capital Management Inc. Sells 46,430 Shares of Halozyme Therapeutics, Inc. $HALO

Victory Capital Management Inc. trimmed its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 6.9% during the third quarter, according to its most recent 13F filing with the...

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.

Current Price	$63.56
Prev Close	$66.48
Open	$65.38
Dividend Yield	0.00%
50-Day Moving Average	$72.35
Beta	0.72
Avg. Volume	2.25M
PE Ratio	26.68

52-Week High	$82.22
52-Week Low	$47.50
Market Capitalization	$7.85B
EPS (Annual)	$2.56
Price to Book	160.41
Revenue Per Employee	$3.3M

HALO
Halozyme Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HALO News

HALOHalozyme Therapeutics Inc.